Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|25|3816-3827

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.25, 2012-07, pp. : 3816-3827

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-6 as a therapy target in oral squamous carcinoma

By Culig Zoran  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 53-59

Informa Healthcare

Access to resources Recommend Favorite

Anti-Interleukin-6 Receptor Antibody Therapy in Rheumatic Diseases

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 373-381

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes

By Barton Beverly E  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 737-752

Informa Healthcare

Access to resources Recommend Favorite

Anti-Interleukin-6 Therapy for Crohn's Disease

By  

Current Pharmaceutical Design, Vol. 9, Iss. 4, 2003-02 ,pp. : 295-305

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance

By  

Current Pharmaceutical Design, Vol. 22, Iss. 5, 2016-02 ,pp. : 518-526

Bentham Science Publishers

Access to resources Recommend Favorite